二重抗血小板治療に関連した脳内出血の特徴
Andrea Morotti1,2, Jawed Nawabi3, Qi Li4
1Department of Clinical and Experimental Sciences, Neurology Unit, University of Brescia, Brescia, Italy. andrea.morotti@unibs.it.
Journal of neurology
|August 30, 2025
まとめ
二重抗血小板治療 (DAPT) は,脳内出血 (ICH) の患者において,血腫の拡大と不良の結果のリスクを有意に増加させる. これは,ICH管理においてDAPTを慎重に考慮する必要性を強調しています.
科学分野:
- 神経科学
- 心臓病科
- 薬理学について
背景:
- 抗血小板治療は,血腫の拡大 (HE) と脳内出血 (ICH) の悪い結果と関連しています.
- 異なる抗血小板療法に伴う特定のリスクを理解することは,患者の管理に極めて重要です.
研究 の 目的:
- 二重抗血小板治療 (DAPT) を受けている患者の脳内出血 (ICH) を特徴付ける.
- DAPTを投与された患者と,単一の抗血小板治療 (SAPT) と抗血小板治療 (NAPT) を投与しなかった患者の血液腫の拡大 (HE) と不良予後を比較する.
主な方法:
- イタリア,ドイツ,中国の9つの学術脳卒中センターで1644人のICH患者を遡及的に分析した.
- 評価されたアウトカムには,血腫の拡大 (HE) と3ヶ月後の予後不良 (修正ランキンスケール4〜6) が含まれていた.
- ロジスティック回帰は,結果の予測確率を計算するために使用され,混同因子を調整しました.
主要な成果:
- 二重抗血小板治療 (DAPT) は,SAPT (31% HE, 55% の悪い結果) とNAPT (23% HE, 48% の悪い結果) と比較して,HE (42%) と悪い結果の最も高いリスクに関連していました.
- アスピリンとクロピドグレルの間では,SAPT群でHEの有意な差異や悪い結果は見られなかった.
- すべての比較のP値は< 0. 001で,統計的有意性を示した.
結論:
- 二重抗血小板治療 (DAPT) は,血腫の拡大と急性脳内出血 (ICH) の不良予後を有意に高めている.
- これらの発見は,ICH患者の臨床意思決定と将来の研究において,DAPTのリスクを考慮することの重要性を強調しています.
関連する概念動画
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
644
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
644
Anticoagulant Drugs: Low-Molecular-Weight Heparins
889
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
889
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Coronary Artery Disease V: Interprofessional Care
30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
Formation of the Platelet Plug
7.1K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.1K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K


